Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
In December 2023, Occam placed Dr. Rajiv Patni as Strategic Clinical Advisor to CEO Vimal Mehta and the Board of Directors at BioXcel Therapeutics.
Dr. Patni served as Chief Research and Development Officer at Reata Pharmaceuticals, a commercial-stage firm recently acquired by Biogen. Prior to that, he experienced substantial success as CMO of multiple public small-cap, commercial-stage biopharma companies, including Adamas, Portola, and Global Blood Therapeutics. He joined these companies at a turning point in their R&D growth trajectories and contributed to their acquisition by larger firms. Earlier in his career, Dr. Patni had roles of increasing responsibility at Pfizer, Roche, and Actelion.
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. Occam is a leader in recruiting artificial intelligence and machine learning talent for the life sciences, having partnered with insitro, Recursion, GSK, Atomic AI, Relation, Chemify, LabGenius, Nucleome, Charm Therapeutics, Anagenex, and ZebiAI.
_460x368.avif)
View recent Placements
.avif)
.avif)
.avif)
.avif)
DISCOVER OCCAM GLOBAL
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies.
Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.